BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Topica Pharmaceuticals 

435 Tasso Street
Suite 325
Palo Alto  California  94301  U.S.A.
Phone: 650-473-3800 Fax: 650-473-3805


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Topica Pharmaceuticals Presents Interim Safety and Mycologic Results From Its Phase 2b/3 Onychomycosis Trial of 10% Luliconazole Solution at the Interscience Conference on Antimicrobial Agents and Chemotherapy 9/11/2013 9:29:03 AM    More...
Topica Pharmaceuticals Presents Findings From Phase 1/2 Trial of Luliconazole Solution, 10% in Onychomycosis at ICAAC 2012 9/14/2012 9:05:39 AM    More...
Topica Pharmaceuticals Initiates Phase 2b/3 Study of Luliconazole in Patients With Onychomycosis of the Toenails 6/27/2012 9:05:21 AM    More...
Topica Pharmaceuticals Presents Promising Luliconazole Solution, 10% Data in Onychomycosis at 2012 American Academy of Dermatology Annual Meeting 3/19/2012 8:41:40 AM    More...
Topica Pharmaceuticals Names Dr. Amir Tavakkol Senior Vice President of Clinical Development and Operations 12/5/2011 9:07:29 AM    More...
Geron Corporation (GERN): A Tribute to Alex Barkas 11/23/2011 10:06:47 AM    More...
Topica Pharmaceuticals Announces Completion of $27 Million Series B Financing 10/18/2011 6:52:48 AM    More...
Topica Pharmaceuticals Announces Positive Results From Phase 1/2a Trial of Luliconazole for Treatment of Onychomycosis 6/20/2011 10:10:50 AM    More...
Topica Pharmaceuticals Announces Appointment of David E. Cohen, M.D., to Board of Directors 3/28/2011 9:31:13 AM    More...
Topica Pharmaceuticals Announces Enrollment of First Patient in Phase 1/2a Trial of Luliconazole for Treating Onychomycosis 1/11/2011 8:48:12 AM    More...
12

//-->